Absolute Neutrophil Count (ANC)
ورودیهای بالینی بیمار
حداقل ۰.۱ — حداکثر ۱۰۰ • واحد: x 10³/mm³
حداقل ۰ — حداکثر ۱۰۰ • واحد: %
حداقل ۰ — حداکثر ۱۰۰ • واحد: %
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- Severe Neutropenia0–500
- Moderate Neutropenia500–1000
- Mild Neutropenia1000–1500
- Normal1500–20000
The Absolute Neutrophil Count (ANC) calculates determining thromboembolic risk, heparin-induced thrombocytopenia probability, and bleeding diathesis. Key inputs include wbc count. Scores guide initiating targeted anticoagulation therapy, platelet monitoring, or hematology specialist referral. This standardized assessment improves clinical decision safety and bedside patient management.
Clinical Guidelines & Evidence
Frequently used to assess febrile neutropenia in chemotherapy patients, by calculating the total number of mature and immature neutrophils
Clinical Indication
The Absolute Neutrophil Count (ANC) is indicated for bedside clinical practice to support Frequently used to assess febrile neutropenia in chemotherapy patients, by calculating the total number of mature and immature neutrophils. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Patients presenting with coagulopathy, thrombocytopenia, venous thromboembolism (DVT/PE), or hematologic neoplasms. Clinical application is indicated across Hematology-oncology services, bone marrow transplant units, anticoagulation clinics, and acute medical wards.
Limitations & Contraindications
Severe thrombocytopenia with concomitant microvascular thrombosis (TTP, HIT, DIC) represents a medical emergency requiring rapid intervention.
Clinical Pearls & Action Plan
Detailed history of heparin exposure, platelet count kinetics, and comprehensive coagulation profiles are vital in consumptive coagulopathies.
ANC = WBC × [(% Segmented Neutrophils + % Band Neutrophils) / 100]
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| wbc_count | float | Yes | White blood cell count (WBC)(x 10³/mm³) |
| segmented_neutrophils | float | Yes | Percentage of segmented (mature) neutrophils(%) |
| band_neutrophils | float | Yes | Percentage of band (immature) neutrophils(%) |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| 0–500 | Severe Neutropenia | High infection risk |
| 500–1000 | Moderate Neutropenia | Moderate infection risk |
| 1000–1500 | Mild Neutropenia | Mild infection risk |
| 1500–20000 | Normal | Normal count |
Evidence-Based References (EBM)
- Klastersky J, de Naurois J, Rolston K, et al. Management of febrile neutropaenia: ESMO Clinical Practice Guidelines. Ann Oncol. 2016;27(suppl 5):v111-v118.
- Freifeld AG, Bow EJ, Sepkowitz KA, et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america. Clin Infect Dis. 2011;52(4):e56-93.